Navigation Links
Recurrence of bowel cancer cut down by Radiotherapy

Researchers reported that radiotherapy given to bowel cancer patients before the surgical removal of the tumour, than later, can cut down// the risk of recurrence to 1 %. The usual treatment for bowel cancer is surgery. However, the risk of recurrence is there and once reappeared, treatment is difficult and usually incurable.

The British scientists conducted an international study, to compare the effect of radiotherapy before and after the surgery, on 1,350 patients in Britain, Canada, South Africa and New Zealand. Lower recurrence rate and a better five-year survival rate was observed in the patients given radiotherapy before the surgery.

"The results of the CR07 trial show that giving a patient radiotherapy before rectal surgery gives them the best chance of avoiding re-growth of the cancer and of survival in the longer term," said Dr David Sebag-Montefiore, of the Cookridge Hospital in Leeds. This trial was presented at the National Cancer Research Institute (NCRI) meeting in Birmingham, England.

The pre-operative group patients were given 5 sessions of radiotherapy every day for 2 weeks followed by surgery whereas, in the post-operative group, surgery was followed by 25 radiotherapy sessions for 5 weeks and chemotherapy if required.

In the pre-operative group, 5 % of the patients showed local recurrence of the cancer after 5 years, where as in the post-operative group, 17% of patients showed recurrence. The former had 75% chances for 5-year survival while the latter had 67%.

"This is good news for patients and clinicians alike and could lead to an increase in the use of pre-operative therapy," Sebag-Montefiore added in a statement.

Almost 0.5 million people across the world die due to bowel cancer every year. The International Agency for Research on Cancer (IARC) revealed that bowel cancer is the second most common cancer in the developed countries.
GYT
'"/>




Page: 1

Related medicine news :

1. Lowering Risk of Breast Cancer Recurrence
2. HRT Found To Increase Recurrence of Breast Cancer
3. The Link Between HRT And Recurrence of Breast Cancer
4. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
5. Predicting Breast Cancer Recurrence By Understanding Gene Signature
6. Combination Therapy To Avoid Prostate Cancer Recurrence
7. Recurrence of aggressive uterine cancer reduced by new form of therapy
8. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
9. Drugs Are Effective In Treating Depression and Preventing Recurrence
10. PET-CT Scores High On Precision for Diagnosing Ovarian Cancer Recurrence
11. Experts Warn of Bird Flu Recurrence in Maharashtra
Post Your Comments:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 1Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 2Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 1Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 1Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 3Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 4